Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.

[1]  C. Houser,et al.  Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy. , 2014, Brachytherapy.

[2]  A. Damato,et al.  Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer. , 2013, Gynecologic oncology.

[3]  M. Steinberg,et al.  Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy. , 2013, International journal of radiation oncology, biology, physics.

[4]  D. D'Souza,et al.  Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. , 2013, International journal of radiation oncology, biology, physics.

[5]  C. Houser,et al.  Dosimetric Comparison of Multi-Channel Vaginal Cylinder High-Dose-Rate Brachytherapy to One Single Channel Vaginal Cyliner for Patients with Vaginal Cancer , 2013 .

[6]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[7]  C. Haie-meder,et al.  Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  C. Houser,et al.  Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer. , 2012, Brachytherapy.

[9]  L. V. van de Poll-Franse,et al.  Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Zola,et al.  Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. , 2010, European journal of cancer.

[11]  John C Roeske,et al.  Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[12]  D. Heron,et al.  Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. , 2006, Gynecologic oncology.

[13]  D. Provencher,et al.  Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence. , 2006, Gynecologic oncology.

[14]  P. Grigsby,et al.  Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. , 2005, International journal of radiation oncology, biology, physics.

[15]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[16]  A. Jhingran,et al.  Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. , 2003, International journal of radiation oncology, biology, physics.

[17]  P. Koper,et al.  Survival after relapse in patients with endometrial cancer: results from a randomized trial. , 2003, Gynecologic oncology.

[18]  J. Jassem,et al.  Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[19]  A. Fyles,et al.  Results of radical radiotherapy for recurrent endometrial cancer. , 2000, Gynecologic oncology.

[20]  T. Wong,et al.  The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[21]  F. Shamsa,et al.  Radiation therapy for endometrial cancer in patients treated for postoperative recurrence. , 1998, International journal of radiation oncology, biology, physics.

[22]  B. Clark,et al.  Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. , 1997, Gynecologic oncology.

[23]  E. Franssen,et al.  Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. , 1996, Gynecologic oncology.

[24]  K. Greven,et al.  Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer , 1994, Cancer.

[25]  K. Degeest,et al.  Isolated vaginal recurrences of endometrial carcinoma. , 1993, Radiology.

[26]  P. Koper,et al.  Recurrent endometrial adenocarcinoma after surgery alone: prognostic factors and treatment. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  S. Davidson,et al.  Treatment Failure in Endometrial Carcinoma , 1990, Obstetrics and gynecology.

[28]  W. Curran,et al.  Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. , 1988, International journal of radiation oncology, biology, physics.

[29]  B. Sorbe,et al.  Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy. , 2013, Anticancer research.

[30]  J. Rownd,et al.  American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. , 2012, Brachytherapy.